Park Ha Biological Technology (BYAH) Receivables - Net (2023 - 2026)

Park Ha Biological Technology (BYAH) has reported Receivables - Net for 4 consecutive years, with -$3.5 million the latest figure, recorded in Q2 2026.

• Quarterly Receivables - Net fell 453.36% year-over-year to -$3.5 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$3.5 million (down 453.36% YoY) and the FY2025 annual result came in at -$3.1 million, down 369.48% from the prior year.
• Receivables - Net declined to -$3.5 million in Q2 2026 per BYAH's latest filing, from -$3.1 million in the prior quarter.
• Over the last five years, Receivables - Net for BYAH reached as high as $996605.0 in Q2 2025 and fell as low as -$3.5 million in Q2 2026.
• A 4-year average of -$970931.2 and a median of $66106.0 in 2023 frame the typical range for Receivables - Net.
• Annual changes were most pronounced in 2024 — Receivables - Net surged 1028.48% — and 2025, when it plunged 521.16%.
• Year by year, Receivables - Net stood at $66106.0 in 2023, then jumped by 1028.48% to $745992.0 in 2024, then tumbled by 521.16% to -$3.1 million in 2025, then dropped by 12.09% to -$3.5 million in 2026.
• According to Business Quant data, Receivables - Net over the past three periods registered -$3.5 million, -$3.1 million, and $996605.0 for Q2 2026, Q4 2025, and Q2 2025 respectively.